JP2023512294A5 - - Google Patents
Info
- Publication number
- JP2023512294A5 JP2023512294A5 JP2022547055A JP2022547055A JP2023512294A5 JP 2023512294 A5 JP2023512294 A5 JP 2023512294A5 JP 2022547055 A JP2022547055 A JP 2022547055A JP 2022547055 A JP2022547055 A JP 2022547055A JP 2023512294 A5 JP2023512294 A5 JP 2023512294A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- sequence
- poxvirus
- fragments
- dna fragments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062969628P | 2020-02-03 | 2020-02-03 | |
| US62/969,628 | 2020-02-03 | ||
| US202063113803P | 2020-11-13 | 2020-11-13 | |
| US63/113,803 | 2020-11-13 | ||
| PCT/US2021/016247 WO2021158565A2 (en) | 2020-02-03 | 2021-02-02 | Poxvirus-based vectors produced by natural or synthetic dna and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023512294A JP2023512294A (ja) | 2023-03-24 |
| JP2023512294A5 true JP2023512294A5 (https=) | 2024-02-09 |
Family
ID=77200801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547055A Pending JP2023512294A (ja) | 2020-02-03 | 2021-02-02 | 天然ｄｎａまたは合成ｄｎａによって作製されたポックスウイルスベースのベクターおよびその使用法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4100514A4 (https=) |
| JP (1) | JP2023512294A (https=) |
| KR (1) | KR20220148823A (https=) |
| CN (1) | CN115397998A (https=) |
| AU (2) | AU2021217073A1 (https=) |
| BR (1) | BR112022014738A2 (https=) |
| CA (1) | CA3168836A1 (https=) |
| IL (1) | IL294926A (https=) |
| MX (1) | MX2022009200A (https=) |
| WO (1) | WO2021158565A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4103231A4 (en) | 2020-02-14 | 2024-03-27 | Geovax, Inc. | VACCINES AND THEIR USES TO INDUCE AN IMMUNE RESPONSE AGAINST SARS-COV2 |
| EP4153228A4 (en) | 2020-05-17 | 2024-07-10 | City of Hope | CORONAVIRUS VACCINES BASED ON SYNTHETIC MODIFIED ANKARA VACCINE (SMVA) VIRUS |
| JP2024505274A (ja) | 2021-02-02 | 2024-02-05 | ゲオバックス インコーポレイテッド | ワクチン接種中のｔ細胞プライミングの強化において使用されるウイルスコンストラクト |
| CN115433741A (zh) * | 2022-06-23 | 2022-12-06 | 广西大学 | 盖他病毒为载体表达报告蛋白的重组病毒的构建方法 |
| CN118240879A (zh) * | 2023-11-01 | 2024-06-25 | 上海市重大传染病和生物安全研究院 | 骨架质粒、重组质粒以及猴痘病毒颗粒和应用 |
| CN119506355B (zh) * | 2025-01-15 | 2025-10-17 | 中国人民解放军军事科学院军事医学研究院 | 一种用于重组痘病毒包装的载体系统及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3788142A4 (en) * | 2018-05-02 | 2022-04-27 | Tonix Pharma Holdings Limited | SYNTHETIC CHIMERIC VACCINE VIRUS |
-
2021
- 2021-02-02 CA CA3168836A patent/CA3168836A1/en active Pending
- 2021-02-02 CN CN202180025623.2A patent/CN115397998A/zh active Pending
- 2021-02-02 MX MX2022009200A patent/MX2022009200A/es unknown
- 2021-02-02 WO PCT/US2021/016247 patent/WO2021158565A2/en not_active Ceased
- 2021-02-02 EP EP21750239.2A patent/EP4100514A4/en active Pending
- 2021-02-02 IL IL294926A patent/IL294926A/en unknown
- 2021-02-02 AU AU2021217073A patent/AU2021217073A1/en active Pending
- 2021-02-02 JP JP2022547055A patent/JP2023512294A/ja active Pending
- 2021-02-02 BR BR112022014738A patent/BR112022014738A2/pt unknown
- 2021-02-02 KR KR1020227030182A patent/KR20220148823A/ko active Pending
-
2025
- 2025-12-24 AU AU2025287330A patent/AU2025287330A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023512294A5 (https=) | ||
| WO2024015510A1 (en) | Sars-cov-2 lacking the envelope protein as an attenuated vaccine virus against covid-19 | |
| JP7092663B2 (ja) | 組換えオルフウイルスベクター | |
| CN110036020A (zh) | 具有狂犬病病毒抗原的黑猩猩腺病毒构建体 | |
| JP2537345B2 (ja) | 狂犬病に対するワクチン及びその製造法 | |
| JP2026041921A5 (https=) | ||
| US12180512B2 (en) | Simian adenoviral vectors with two expression cassettes | |
| JP2023526073A5 (https=) | ||
| AU2025287330A1 (en) | Poxvirus-based vectors produced by natural or synthetic DNA and uses thereof | |
| EP4396333A1 (en) | Utilization of micro-rna for downregulation of cytotoxic transgene expression by modified vaccinia virus ankara (mva) | |
| JP2020537525A (ja) | 複製能力のあるアデノウイルスベクター | |
| EP4527933A1 (en) | Dual-carrier system for treating hearing damage, and use thereof | |
| EP3697919A1 (en) | Adenoviral vectors with two expression cassettes encoding rsv antigenic proteins or fragments thereof | |
| Lundstrom | Application of viruses for gene therapy and vaccine development | |
| EP4368203A1 (en) | Construction and use of anti-vegf antibody in-vivo expression system | |
| CN102086453B (zh) | 以粘蛋白1和生存素为靶点的肿瘤dna疫苗及病毒载体疫苗 | |
| CA3249426A1 (en) | CONSTRUCTION OF NUCLEIC ACID FOR THE TREATMENT OF AN INHERITED COAGULATION FACTOR DEFICIENCY AND ITS USE | |
| US20250215456A1 (en) | Poxvirus-based vectors produced by natural or synthetic dna and uses thereof | |
| WO2006002594A1 (en) | A recombinant canine adenovirus type-2 and the preparation method and usage thereof | |
| KR101420564B1 (ko) | ＴＧＦ－β２ 발현을 억제하는 ｓｈＲＮＡ | |
| CN102892428A (zh) | 表达兔出血热病毒的vp60主要衣壳蛋白的副痘病毒 | |
| CN105879060A (zh) | 成纤维激活蛋白α为靶点的肿瘤DNA疫苗及病毒载体疫苗 | |
| US20250235527A1 (en) | Synthetic modified vaccinia ankara (smva) based coronavirus vaccines | |
| JP2022508835A5 (https=) | ||
| CN114591921B (zh) | 腺相关病毒的纯化方法和洗脱液 |